Sobre 9 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the detailed record of transactions filed by Bitterman Robert J, Consejero. Officer active across 1 company, notably Phio Pharmaceuticals Corp.. In total, 27 filings have been recorded. Breakdown: 19 buys · 0 sell. Total volume traded: €52k. Activity tracked since 15 February 2022. The latest transaction was filed on 18 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Bitterman Robert J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 títulos@ 1750,00 US$9.1% de su flujoSeries D Preferred Stock, $0.0001 par valueSEC:0001209191-22-057333:0
Salida canónica: 14 feb 2023 (T+90)
25 de 27 declaraciones
About Bitterman Robert J
Bitterman Robert J is Administrateur and serves at Phio Pharmaceuticals Corp. as Chairman, Pres. & CEO. He has filed 26 forms in total, and across the 26 sampled filings from 2022-02-16 to 2026-06-29, the transactions are acquisitions with total purchases of EUR 42863 and no sales reported.